-
Science Journal, June 5, 2020
Time of Update: 2020-06-16
June 12, 2020 /PRNewswire/ -- BioValley BIOON/--- This week has another new journal of Science (June 5, 2020) out Let the little ones come together Photo from the Journal of Science 1.Science: NELL2-m
-
Gut: Scientists identify special memory NK cells that could help improve vaccine and treatment strategies to fight HBV infection
Time of Update: 2020-06-16
JUNE 12, 2020 /PRNewswire/ -- In a recent study published in the international journal Gut, scientists from the Westmead Institute of Medicine and other institutions have discovered for the first time
-
Science: A major breakthrough! Scientists have developed an ultra-fast CRISPR-Cas9 gene editing technology that enables precise gene editing in seconds!
Time of Update: 2020-06-16
JUNE 14, 2020 /PRNewswire/ -- In a recent study published in the international journal Science, scientists from Johns Hopkins University and others developed a new way to accelerate the process of CRI
-
Ann Rheum Dis: Prevalence of bone marrow edema in early and late postnatal women
Time of Update: 2020-06-16
The purpose of this study was to determine the prevalence of bone marrow edema (BME) in women with early postnatal (EPP), unborn (NP) and late postnatal (LPP) female joints (SIJ) and to identify fact
-
J Rheumatol: Large vasculitis affecting recurrent polycartilitis aorta and its branches
Time of Update: 2020-06-16
The study was designed to describe the characteristics of large vascular angiotin (LVV) that affect the aorta and its branches in patients with recurrent polycartilitis (RP) The study uses retrospect
-
Med: COVID-19 patients treated with hydroxychloroquine have no survival benefits
Time of Update: 2020-06-16
11, 2020 /PRNewswire/ -- An electronic medical record study from the U.S Veterans Health Administration Medical Center found that hydroxychloroquine -- whether used in combination with azithromycin --
-
Hum Vaccin Immunother: Persistence of immune response after 4CMenB vaccination
Time of Update: 2020-06-16
Multi-component meningoccal serogroup B vaccine 4CMenB has been shown to be effective in preventing invasive MenB disease in infants and controlling MenB outbreaks No additional enhanced dose/timing
-
NEJM: New Discovery! COVID-19 infection may induce the development of new type of diabetes in patients!
Time of Update: 2020-06-16
14, 2020 /PRNewswire/ -- There is research evidence that COVID-19 infection may cause diabetes in healthy populations, as well as severe complications of diabetes, and a recent study published in the
-
Antibody drug conjugate ILUMYA (tildrakizumab-asmn) treatment of moderate-severe plaqueized psoriasis: good long-term safety effectiveness
Time of Update: 2020-06-16
The pharmaceutical company Sun today announced that it will present the long-term use and cost-benefit analysis of ILUMYATM (tildrakizumab-asmn, targeting IL-23) for the treatment of moderate to seve
-
JCEM: People who don't eat on time pay attention! Eating late for dinner makes it easier to increase your weight and blood sugar levels!
Time of Update: 2020-06-16
JUNE 14, 2020 /PRNewswire/ -- In a recent study published in the international journal Journal of Clinical Endocrinology and Metabolism, scientists from institutions such as Johns Hopkins University f
-
A new drug for epidermatitis! Pfizer's next-generation oral JAK1 inhibitor abrocitinib 4 Phase III clinical studies have been successful!
Time of Update: 2020-06-16
June 11, 2020 /PRNewswire/ -- Pfizer has announced that the evaluation of an oral JAK1 inhibitor abrocitinib (PF-04965842) for treatment at an age of 12-18 years and also receiving background external
-
EULAR 2020: Head-to-head PHASE III study confirms AbbVie's JAK1 inhibitor upadacitinib treatment of rheumatoid arthritis, better than CTLA-4-Fc fusion protein abatacept
Time of Update: 2020-06-16
At the 2020 European Rheumatology Alliance Annual Meeting (EULAR 2020), AbbVie announced the latest data from the third select-CHOICE clinical trial, which showed that its JAK1 inhibitor, RINVOQ (upa
-
Sci Adv: The latest research results of the Chinese Academy of Sciences! R-ring structure may be able to coordinate with transcription factor Sox2 to regulate the pluripotency of cell reprogramming
Time of Update: 2020-06-16
June 14, 2020 /PRNewswire/ -- The special structure in R-loops cells, consisting of RNA-DNA hybrids and replaceable single-stranded DNA, is usually found near transcription genes, however, the R ring
-
Ann Rheum Dis: Similar to Kawasaki disease, multisystem inflammatory syndrome in children associated with SARS-CoV-2 (Kawa-COVID-19)
Time of Update: 2020-06-16
Current data show that the prevalence of COVID-19 in children is low and the incidence is mild But the number of children visiting hospitals in the greater Paris region in the past few weeks, similar
-
Nat Commun: New Discovery! Scientists reveal a close link between liver disease and heart disease!
Time of Update: 2020-06-16
June 14, 2020 /PRNewswire/ -- In a recent study published in the international journal Nature Communications, scientists from Iowa State University and other institutions studied the heart health of f
-
Arthritis Rheumatol: Atherosclerosis Vascular Events in multi-center SLE queues
Time of Update: 2020-06-16
In previouspublished articles, about 10% of SLE patients develop atherosclerosis vascular events (AVE) The study was designed to investigate the annual incidence and potential risk factors of AVE in
-
Blood: immune deficiency and lymphoma in children due to loss of function of the germ lineTE TET2
Time of Update: 2020-06-16
Molecular anatomy of immunity birth defects helps to clarify the non-redundant function of individual genes Spegarova and others studied three children with immunodisordersyndrome who exhibit lymphom
-
Nat Commun: Study reveals 'hot spots' in lymphatic tube formation
Time of Update: 2020-06-16
June 13, 2020 /PRNewswire/ --- During embryonic development, the development of the lymphatic tube system is critical to the development of a specific protein-growth factor VEGF-C However, so far, we
-
EU regulators begin review of LEO's IL-13 monoanti-tralokinumab to treat adhetular dermatitis
Time of Update: 2020-06-16
The Eu drug regulator has begun a review of LEO Pharma's leukocyte interleukin 13 (IL-13) monoanti-tralokinumab treatment for moderate to severe adhesional dermatitis The drug is an all-human monocl
-
Sci Adv: Heavyweight! Chinese scientists' successful conversion of the spleen into a liver-like organ could solve the dilemma facing liver organ transplantation.
Time of Update: 2020-06-16
JUNE 14, 2020 /PRNewswire/ -- In a recent study published in the international journal Science Advances, scientists from Nanjing University and other institutions have developed a new method or can in
